Jinzhong Lin

发表

Dual Ethanolamine Head Groups in Ionizable Lipids Facilitate Phospholipid-free Stable Nanoparticle Formulation for Augmented and Safer mRNA Delivery

D. Ouyang, Hang Yu, Hongwei Yao, 2023, bioRxiv.

Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial

Qianhui Wu, Y. Zou, Zhonghan Sun, 2023, EClinicalMedicine.

NOP14-mediated ribosome biogenesis is required for mTORC2 activation and predicts rapamycin sensitivity

Lin Feng, Ruihua Wang, Xiao Yan, 2024, The Journal of biological chemistry.

Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies

Xue Hu, Hui Zhou, Hang Yu, 2024, Emerging microbes & infections.